<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zenkel M</submitter><funding>The Glaucoma Foundation New York (The Barry Friedberg and Charlotte Moss Family Foundation)</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>The Glaucoma Foundation New York</funding><pagination>5977</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9180992</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(11)</volume><pubmed_abstract>Pseudoexfoliation (PEX) syndrome, a stress-induced fibrotic matrix process, is the most common recognizable cause of open-angle glaucoma worldwide. The recent identification of PEX-associated gene variants uncovered the vitamin A metabolic pathway as a factor influencing the risk of disease. In this study, we analyzed the role of the retinoic acid (RA) signaling pathway in the PEX-associated matrix metabolism and evaluated its targeting as a potential candidate for an anti-fibrotic intervention. We provided evidence that decreased expression levels of RA pathway components and diminished RA signaling activity occur in an antagonistic crosstalk with TGF-β1/Smad signaling in ocular tissues and cells from PEX patients when compared with age-matched controls. Genetic and pharmacologic modes of</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Dysregulated Retinoic Acid Signaling in the Pathogenesis of Pseudoexfoliation Syndrome.</pubmed_title><pmcid>PMC9180992</pmcid><funding_grant_id>SCHL 366/11-1; PA 2353/4-1</funding_grant_id><funding_grant_id>N.A.</funding_grant_id><funding_grant_id>SCHL 366/11-1</funding_grant_id><funding_grant_id>PA 2353/4-1</funding_grant_id><pubmed_authors>Weller JM</pubmed_authors><pubmed_authors>Schlotzer-Schrehardt U</pubmed_authors><pubmed_authors>Pasutto F</pubmed_authors><pubmed_authors>Konig L</pubmed_authors><pubmed_authors>Hohberger B</pubmed_authors><pubmed_authors>Gießl A</pubmed_authors><pubmed_authors>Hubner L</pubmed_authors><pubmed_authors>Ostermann TA</pubmed_authors><pubmed_authors>Kruse FE</pubmed_authors><pubmed_authors>Gusek-Schneider GC</pubmed_authors><pubmed_authors>Hoja U</pubmed_authors><pubmed_authors>Berner D</pubmed_authors><pubmed_authors>Zenkel M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulated Retinoic Acid Signaling in the Pathogenesis of Pseudoexfoliation Syndrome.</name><description>Pseudoexfoliation (PEX) syndrome, a stress-induced fibrotic matrix process, is the most common recognizable cause of open-angle glaucoma worldwide. The recent identification of PEX-associated gene variants uncovered the vitamin A metabolic pathway as a factor influencing the risk of disease. In this study, we analyzed the role of the retinoic acid (RA) signaling pathway in the PEX-associated matrix metabolism and evaluated its targeting as a potential candidate for an anti-fibrotic intervention. We provided evidence that decreased expression levels of RA pathway components and diminished RA signaling activity occur in an antagonistic crosstalk with TGF-β1/Smad signaling in ocular tissues and cells from PEX patients when compared with age-matched controls. Genetic and pharmacologic modes of</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-25T19:02:00.544Z</modification><creation>2025-02-19T04:56:41.845Z</creation></dates><accession>S-EPMC9180992</accession><cross_references><pubmed>35682657</pubmed><doi>10.3390/ijms23115977</doi></cross_references></HashMap>